ulipristal acetate

Key facts

INN

ulipristal acetate

Brand

ELLA

Route

ORAL

Formulation

TABLET

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12419942

Use of the Salmonella spp type III secretion proteins as a protective vaccinatio

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12390512

Depolymerase capable of degrading extracellular polymeric substances of Klebsiel

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12203143

Methods and kits to identify Klebsiella strains

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12071636

Pasteurella multocida strains and vaccines having hyaC and nanP deletions

Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11717542

Using tumor-navigating Salmonella to modulate tumor metabolism

Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11529312

Francisella lipids as broad anti-inflammatory therapeutics and associated method

Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11519007

Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer

Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11464843

Use of the salmonella SPP type III secretion proteins as a protective vaccinatio

Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is ulipristal acetate?

ulipristal acetate (ELLA), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for ulipristal acetate?

ELLA is a marketed brand name for ulipristal acetate. Check FDA Drugs@FDA for the current US label holder.